You can now read 10 articles a month for free. Read as much as you want anywhere and anytime for just 99¢.

Allergan to cut 1,500 employees in restructuring

NEW YORK — Botox maker Allergan Inc. will cut 13 percent of its workforce to become more efficient as it fights a hostile takeover bid by Valeant Pharmaceuticals International Inc.

The company said it plans to trim about 1,500 employees and 250 vacant positions, and that the restructuring will yield pretax savings of about $475 million in 2015.

Continue reading below

It announced the cuts Monday, the same day it reported second-quarter earnings grew 16 percent to $417.2 million.

‘‘Today’s results demonstrate that we’re clearly on the right path,’’ CEO David Pyott told analysts. ‘‘The actions announced today will only accelerate our trajectory.’’

The drug maker also said that it has raised its forecast for adjusted 2014 earnings to between $5.74 and $5.80 per share. It expects Botox to deliver net sales ranging from $2.2 billion to $2.28 billion.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week